BioSpace News Archive

Several biopharma companies are closing out the month of April with expansions to facilities, including a $3 billion investment to develop next-generation life science ecosystems.

The FDA approval was based on data from the Phase III Explorer-HCM trial that showed Bristol Myers Squibb’s Camzyos could decrease the heart’s contractility.

Since its $63 billion acquisition of Allergan in 2019, AbbVie has become one of the leading companies developing therapies for migraine.

Shares of Praxis Precision Medicines are falling after the company announced the FDA has placed a clinical hold on the company’s IND Application for its experimental epilepsy drug, Prax-222.

Innate Pharma SA announced that AstraZeneca has now dosed the first patient in its Phase 3 clinical trial, PACIFIC-9, evaluating durvalumab in combination with monalizumab or AstraZeneca’s oleclumab in patients with unresectable, Stage III non-small cell lung cancer who have not progressed following definitive platinum-based concurrent chemoradiation therapy.

Albany NY, United States: Baby-cooling sheets are conceived and made for babies in order to give them easy, effective, and rapid relief from fever, thereby improving their well-being and reducing the stress of their parents.

Inspection machines refer to sequence or combination of machines utilized in the inspection of product quality in terms of dimension, leakage, weight, packaging component, and packaging.

DUBAI, United Arab Emirates, Growing inclination towards non-invasive procedures and increasing efficiency of dermal fillers have been driving the dermal fillers market.

Increased use of cryogenic PPE in a wide range of end-use industries across the globe is projected to fuel the expansion of the global cryogenic PPE market between 2020 and 2030.

DUBAI, United Arab Emirates, According to the latest research by the FMI, the global urology imaging systems market is expected to account for over US$ 486.4 Mn, in terms of value, by 2028 end.